HAWKEY CJ, 2012. The Discovery of Helicobacter Pylori. In: THOMPSON GILBERT, ed., Nobel Prizes that Changed Medicine Imperial College Press. 281-307
HAWKEY CJ, BURNETT I, GOLD MS, GARSED K, STEVENSON D, MANNATH J, NORMAN A, SHEPHERD V, SUBRAMANIAN V, JOHNSTON RD and BROWN M, 2012. Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules Aliment Pharm & Therap. 35(7), 819-827 SHERON N, GILMORE I, PARSONS C, HAWKEY CJ and RHODES J, 2012. Projections of alcohol-related deaths in England and Wales—tragic toll or potential prize? The Lancet. 379(9817), 687-688
SUBRAMANIAN V, MANNATH J, TELAKIS E, RAGUNATH K and HAWKEY CJ, 2012. Efficacy of new playback functions at reducing small-bowel wireless capsule endoscopy reading times Dig Dis & Sci. (In Press.)
TARGAN SR and HAWKEY CJ, 2012. Indeterminate Colitis. In: HAWKEY CJ, BOSCH J, RICHTER J E, GARCIA-TSAO G and CHAN FKL, eds., Textbook of Clinical Gastroenterology & Hepatology 2nd. Wiley-Blackwell. 394-398
HAWKEY CJ, BOSCH J, RICHTER JL, GARCIA-TSAO G and CHAN FKL, eds., 2012. Textbook of Clinical Gastroenterology and Hepatology 2nd. Wiley-Blackwell.
HAWKEY CJ, BOSCH J, RICHTER JE, GARCIA-TSAO G and CHAN FKL, 2012. Functional Gastrointestinal Disease. In: HAWKEY CJ, BOSCH J, RICHTER JE, GARCIA-TSAO G and CHAN FKL, eds., Textbook of Clinical Gastroenterology and Hepatology 2nd. Wiley-Blackwell. 54-60
HAWKEY CJ and ATHERTON JC, 2012. Peptic Ulcer. In: HAWKEY CJ, BOSCH J, RICHTER JE, GARCIA-TSAO G and CHAN FKL, eds., Textbook of Gastroenterology and Hepatology 2nd. Wiley-Blackwell. 219-233
NORMAN A and HAWKEY CJ, 2011. What you need to know when you prescribe a proton pump inhibitor Frontline Gastro. 2(4), 199-205
ERHAYIEM, B., DHINGSA, R., HAWKEY, C.J. and SUBRAMANIAN, V., 2011. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn’s disease Clinical Gastroenterology and Hepatology. 9(8), 684-687.e1 BOMBARDIER C, LAINE L, DAY R, HAWKEY CJ, HOCHBERG MC and SCHNITZER TJ, 2011. Rofecoxib and clinically significant gastrointestinal events. American J Med Sci. 342(5), 438-439 SNOWDEN JA, SACCARDI R, ALLEZ M, ARDIZONNE S, ARNOLD R, CERVERA R, DENTON C, HAWKEY CJ, LABOPIN M, MANCARDI G, MARTIN R, MOORE JJ, PASSWEG J, PETERS C, RABUSIN M, ROVIRA M, VAN LAAR JM and FARGE D, 2011. Haematopoietic stem cell transplantation (hsct) in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplantation. 1-21
SUBRAMANIAN V and HAWKEY CJ, 2011. Stem cell transplantation for Crohn’s: will it fulfil its promise?. In: IRVING P, SIEGEL C, RAMPTON D and SHANAHAN E, eds., Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges Ch: 35. Blackwells. 159-163
SHERON N, HAWKEY CJ and GILMORE I, 2011. Projections of alcohol deaths – a wake up call The Lancet. 377(9774), 1297-99
HAWKEY CJ, RHODES J and GILMORE I, 2011. Drugs and harm to society The Lancet. 377(9765), 554
DOHERTY, M., HAWKEY, C., GOULDER, M., GIBB, I., HILL, N., ASPLEY, S. and READER, S., 2011. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain Annals of the Rheumatic Diseases. 70(9), 1534-1541 HART J, HAWKEY CJ, LANAS A, NAESDAL J, TALLEY NJ, THOMSON ABR and YEOMANS ND, 2010. Predictors of gastroduodenal erosions in patients taking low-dose aspirin Aliment Pharmacol & Ther. 31(1), 143-149 MANNATH J, SUBRAMANIAN V, HAWKEY CJ and RAGUNATH K, 2010. Predictors of gastroduodenal erosions in patients taking low-dose aspirin Endoscopy. 42(5), 351-359
HART J, HAWKEY CJ, LANAS A, NAESDAL J, TALLEY NJ, THOMSON AB and YEOMANS ND, 2010. Predictors of gastroduodenal erosions in patients taking low-dose aspirin Aliment Pharmacol & Ther. 31(1), 143-149 HAWKEY CJ, 2010. A new opening for transparency Health Service Journal. 120(6223), 14-15
MELLITS, K.H., CONNERTON, I.F., LOUGHLIN, M.F., CLARKE, P., SMITH, J., DILLON, E., CONNERTON, P.L., MULHOLLAND, F. and HAWKEY,C.J., 2009. Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes BMC Microbiology. 9(1), 28 SUBRAMANIAN V and HAWKEY CJ, 2009. Assessing bleeds clinically: what's the score? The Lancet. 373(9657), 5-7
SINGH R, KARAGEORGIOU H, OWEN V, GARSED K, FORTUN P, FOGDEN E, SUBRAMANIAN V, SHONDE A, KAYE PV, HAWKEY CJ and RAGUNATH K, 2009. Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagus. Scandinavian J Gastroenterol. 44(1), 85-92 HAWKEY CJ, 2009. NSAIDs and aspirin: notorious or FAMOUS? The Lancet. 11(374), 93-99
HAWKEY, C.J., ELL, C., SIMON, B., ALBERT, J., KEUCHEL, M., MCALINDON, M., FORTUN, P., SCHUMANN, S., BOLTEN, W., SHONDE, A., HEUGOT, J.L., YU, V., ARULMANI, U., KRAMER, G., REBULI, R. and TOTH, E., 2008. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole Clinical Gastroenterology and Hepatology. 6(5), 536-544 YEOMANS, N., LANAS, A., LABENZ, J., VELDHUYZEN VAN ZANTEN, S., VAN RENSBERG, C., RÁCZ, I., TCHERNEV, K., KARAMANOLIS, D., RODA, E., HAWKEY, C., NAUCLÉR, E. and SVEDBERG, L.E., 2008. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin American Journal of Gastroenterology. 103(10), 2465-2473 FORTUN P, HAWKEY CJ, CHALKLEY L, WEST J and SHONDE A, 2008. Recall of informed consent information by healthy volunteers in clinical trials Quarterley Journal of Medicine. 101(8), 625-629 BELTINGER J, DEL BUONO J, SKELLY MM, THORNLEY J, SPILLER RC, STACK WA and HAWKEY CJ, 2008. Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells World Journal of Gastroenterology. 14(48), 7345-52 SINGH, R., ANAGNOSTOPOULOS, G.K., YAO, K., KARAGEORGIOU, H., FORTUN, P.J., SHONDE, A., GARSED, K., KAYE, P.V., HAWKEY, C.J. and RAGUNATH, K., 2008. Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology Endoscopy. 40(6), 457-463 YAO K, ANAGNOSTOPOULOS GK, JAWHARI AU, KAYE PV, HAWKEY CJ and RAGUNATH K, 2008. High definition magnification colonosco;y with narrow band imaging (NBI) for visualising mucosal capillaries and red blood cells in the large intestine Gut Liver. 2(1), 14-18
HAWKEY, C.J., WEINSTEIN, W.M., SMALLEY, W., GITTON, X., SALLSTIG, P., STRICKER, K., KRAMMER, G., MELLEIN, B., RICHARD, D. and MATCHABA, P., 2007. Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study. Gastroenterology. 133(1), 57-64 ANAGNOSTOPOULOS, G.K., YAO, K., KAYE, P., HAWKEY, C.J. and RAGUNATH, K, 2007. Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Alimentary Pharmacology and Therapeutics. 26(3), 501-507 ANAGNOSTOPOULOS, G.K., YAO, K., KAYE, P., FOGDEN, E., FORTUN, P., SHONDE, A., FOLEY, S., SUNIL, S., ATHERTON, J.J., HAWKEY, C. and RAGUNATH, K., 2007. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy Endoscopy. 39(3), 202-207 GASPER, A.V., TRAKA, M., BACON, J.R., SMITH, J.A., TAYLOR, M. A., HAWKEY, C.J., BARRETT, D.A. and MITHEN, R.F., 2007. Consuming Broccoli Does Not Induce Genes Associated with Xenobiotic Metabolism and Cell Cycle Control in Human Gastric Mucosa Journal of Nutrition. 137, 1718-1724 GASPER, AMY V, TRAKA, MARIA, BACON, JAMES R, SMITH, JULIE A, TAYLOR, MOIRA A, HAWKEY, CHRISTOPHER J, BARRETT, DAVID A and MITHEN, RICHARD F, 2007. Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa. Journal of Nutrition. 137(7), 1718-24
HAWKEY, C J, JONES, R H, YEOMANS, N D, SCHEIMAN, J M, TALLEY, N J, GOLDSTEIN, J L, AHLBOM, H and NAESDAL, J, 2007. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Alimentary Pharmacology and Therapeutics. 25(7), 813-21 HAWKEY, CHRISTOPHER J, TALLEY, NICHOLAS J, SCHEIMAN, JAMES M, JONES, ROGER H, LÅNGSTRÖM, GÖRAN, NAESDAL, JORGEN, YEOMANS, NEVILLE D and ,, 2007. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis research & therapy. 9(1), R17
MANSFIELD, J C, PARKES, M, HAWTHORNE, A B, FORBES, A, PROBERT, C S J, PEROWNE, R C, COOPER, A, ZELDIS, J B, MANNING, D C and HAWKEY, C J, 2007. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. Alimentary Pharmacology and Therapeutics. 26(3), 421-30 CHEW, ENG-HUI, POOBALASINGAM, THURKA, HAWKEY, CHRISTOPHER J and HAGEN, THILO, 2007. Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization. Cellular Signalling. 19(5), 1071-80 FORTUN, PAUL J and HAWKEY, CHRISTOPHER J, 2007. Nonsteroidal antiinflammatory drugs and the small intestine. Current Opinion in Gastroenterology. 23(2), 134-41 FORTUN, P.J., ANAGNOSTOPOULOS, G.K., KAYE, P., JAMES, M., FOLEY, S., SHONDE, S.A., BADRELDIN, R., CAMPBELL, E., HAWKEY, C.J. and RAGUNATH, K., 2006. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus Alimentary Pharmacology and Therapeutics. 23(6), 735-742 ROLFE, V E, FORTUN, P J, HAWKEY, C J and BATH-HEXTALL, F, 2006. Probiotics for maintenance of remission in Crohn's disease. Cochrane database of systematic reviews (Online). CD004826 ANAGNOSTOPOULOS, G.-K., RAGUNATH, K., SHONDE, A., HAWKEY, C.J. and YAO, K., 2006. Diagnosis of autoimmune gastritis by high resolution magnification endoscopy World journal of gastroenterology : WJG. 12(28), 4586-7
HAWKEY, C.J., GITTON, X., HOEXTER, G., RICHARD, D. and WEINSTEIN, W.M., 2006. Gastrointestinal tolerability of lumiracoxib in patients with osteoarthritis and rheumatoid arthritis Clinical Gastroenterology and Hepatology. 4(1), 57-66 CAPRILLI, R., GASSULL, M.A., ESCHER, J.C., MOSER, G., MUNKHOLM, P., FORBES, A., HOMMES, D.W., LOCHS, H., ANGELUCCI, E., COCCO, A., VUCELIC, B., HILDEBRAND, H., KOLACEK, S., RIIS, L., LUKAS, M., DE FRANCHIS, R., HAMILTON, M., JANTSCHEK, G., MICHETTI, P., O'MORAIN, C. and ANWAR, M., 2006. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations Gut. 55 Suppl 1, i36-58 BOMBARDIER, CLAIRE, LAINE, LOREN, BURGOS-VARGAS, RUBEN, DAVIS, BARRY, DAY, RICHARD, FERRAZ, MARCOS BOSI, HAWKEY, CHRISTOPHER J, HOCHBERG, MARC C, KVIEN, TORE K, SCHNITZER, THOMAS J and WEAVER, ARTHUR, 2006. Response to expression of concern regarding VIGOR study. The New England journal of medicine. 354(11), 1196-9 GASPER, A.V., AL-JANOBI, A., SMITH, J.A., BACON, J.R., FORTUN, P., ATHERTON, C., TAYLOR, M.A., HAWKEY, C.J., BARRETT, D.A. and MITHEN, R.F., 2005. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli American Journal of Clinical Nutrition. 82(6), 1283-1291 TATA, L.J., FORTUN, P.J., HUBBARD, R.B., SMEETH, L., HAWKEY, C.J., SMITH, C.J.P., WHITAKER, H.J., FARRINGTON, C.P., CARD, T.R. and WEST, J., 2005. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Alimentary Pharmacology and Therapeutics. 22(3), 175-181 FORTUN, P.J. and HAWKEY, C.J., 2005. Nonsteroidal antiinflammatory drugs and the small intestine Current Opinion in Gastroenterology. 21(2), 169-175 HAWKEY, C.J. and FORTUN, P.J., 2005. Cyclooxygenase-2 inhibitors. Current Opinion in Gastroenterology. 21(6), 660-664 FORTUN, P.J. and HAWKEY, C.J., 2005. Life after Vioxx: the clinical implications Hospital Medicine (London). 66(5), 264-7
YEOMANS, N.D., LANAS, A.I., TALLEY, N.J., THOMSON, A.B.R., DANESHJOO, R., ERIKSSON, B., APPELMAN-ESZCZUK, S., LÅNGSTRÖM, G., NAESDAL, J., SERRANO, P., SINGH, M., SKELLY, M.M. and HAWKEY, C.J., 2005. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Alimentary Pharmacology and Therapeutics. 22(9), 795-801 TRAKA, M., GASPER, A.V., SMITH, J.A., HAWKEY, C.J., BAO, Y. and MITHEN, R.F., 2005. Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane Journal of Nutrition. 135(8), 1865-1872
HAWKEY, C.J., 2005. COX-2 chronology. Gut. 54(11), 1509-1514 SCHNITZER, T.J., BURMESTER, G.R., MYSLER, E., HOCHBERG, M.C., DOHERTY, M., EHRSAM, E., GITTON, X., KRAMMER, G., MELLEIN, B., MATCHABA, P., GIMONA, A. and HAWKEY, C.J., 2004. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications : randomised controlled trial Lancet. 364(9435), 665-674 FARKOUH, M.E., KIRSHNER, H., HARRINGTON, R.A., RULAND, S., VERHEUGT, F.W.A., SCHNITZER, T.J., BURMESTER, G.R., MYSLER, E., HOCHBERG, M.C., DOHERTY, M., EHRSAM, E., GITTON, X., KRAMMER, G., MELLEIN, B., GIMONA, A., MATCHABA, P., HAWKEY, C.J. and CHESEBRO, J.H., 2004. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial Lancet. 364(9435), 675-684 ATHERTON, C., JONES, J., MCKAIG, B., BEBB, J., CUNLIFFE, R., BURDSALL, J., BROUGH, J., STEVENSON, D., BONNER, J., RORDORF, C., SCOTT, G., BRANSON, J. and HAWKEY, C.J., 2004. Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: an integrated study Clinical Gastroenterology and Hepatology. 2(2), 113-120 HAWKEY, C.J., FARKOUH, M., GITTON, X., EHRSAM, E., HUELS, J. and RICHARDSON, P., 2004. Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics Alimentary Pharmacology and Therapeutics. 20(1), 51-63 KIVITZ, A.J., NAYIAGER, S., SCHIMANSKY, T., GIMONA, A., THURSTON, H.J. and HAWKEY, C., 2004. Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis Alimentary Pharmacology and Therapeutics. 19(11), 1189-1198 PATHMAKANTHAN, S., LI, C.K.F., COWIE, J. and HAWKEY, C.J., 2004. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon Journal of Gastroenterology and Hepatology. 19(2), 166-173 HAWKEY, C.J., 2004. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis? Alimentary Pharmacology and Therapeutics. 20(Supp/2), 59-64 HAWKEY, C.J., 2004. Stem cell transplantation for Crohn's disease Best Practice & Research: Clinical Haematology. 17(2), 317-325 JACKSON, L., WAHLI, W., MICHALIK, L., WATSON, S.A., MORRIS, T., ANDERTON, K., BELL, D.R., SMITH, J.A., HAWKEY, C.J. and BENNETT, A.J., 2003. Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer Gut. 52(9), 1317-1322 HAWKEY, C.J., JONES, J.I., ATHERTON, C.T., SKELLY, M.M., BEBB, J.R., FAGERHOLM, U., JONZON, B., KARLSSON, P. and BJARNASON, I.T., 2003. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans Gut. 52(11), 1537-1542 LAINE, L., CONNORS, L.G., REICIN, A., HAWKEY, C.J., BURGOS-VARGAS, R., SCHNITZER, T.J., YU, Q. and BOMBARDIER, C., 2003. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use Gastroenterology. 124(2), 288-292 HAWKEY, C.J., ATHERTON, J.C., TREICHEL, H.C., THJODLEIFSSON, B. and RAVIC, M., 2003. Safety and efficacy of 7-day rebeprazole-and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease Alimentary Pharmacology and Therapeutics. 17(8), 1065-1074 DALLOB, A., HAWKEY, C.J., GREENBERG, H., WIGHT, N., DE SCHEPPER, P., WALDMAN, S., WONG, P., DETORA, L., GERTZ, B., AGRAWAL, N., WAGNER, J. and GOTTESDIENER, K., 2003. Characterization of etoricoxib, a novel, selective COX-2 inhibitor Journal of Clinical Pharmacology. 43(6), 573-585 SKELLY, M.M. and HAWKEY, C.J., 2003. Dual COX inhibition and upper gastrointestinal damage Current Pharmaceutical Design. 9(27), 2191-2195 WIKLUND, I.K., FULLERTON, S., HAWKEY, C.J., JONES, R.H., LONGSTRETH, G.F., MAYER, E.A., PEACOCK, R.A., WILSON, I.K. and NAESDAL, J., 2003. An irritable bowel syndrome-specific symptom questionnaire: development and validation Scandinavian Journal of Gastroenterology. 38(9), 947-954 SKELLY, M.M. and HAWKEY, C.J., 2003. COX-LOX inhibition: current evidence for an emerging new therapy International Journal of Cinical Practice. 57(4), 301-304
JONZON, B., BJARNASON, I., HAWKEY, C., JONES, J., GODDARD, A., FAGERHOLM, U. and KARLSSON, P., 2003. The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers Inflammopharmacology. 11(4/6), 437-444 HAWKEY, C.J., LAINE, L., SIMON, T., QUAN, H., SHINGO, S. and EVANS, J., 2003. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study Gut. 52(6), 820-826 LAINE, L., BOMBARDIER, C., HAWKEY, C.J., DAVIS, B., SHAPIRO, D., BRETT, C. and REICIN, A., 2002. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis Gastroenterology. 123(4), 1006-1012 HAWKEY, C.J., WILSON, I., NAESDAL, J., LÅNGSTRÖM, G., SWANNELL, A.J. and YEOMANS, N.D., 2002. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users Gut. 51(3), 344-350 STACK, W.A., ATHERTON, J.C., HAWKEY, G.M., LOGAN, R.F.A. and HAWKEY, C.J., 2002. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding Alimentary Pharmacology and Therapeutics. 16(3), 497-506 SKELLY, M.M., LOGAN, R.F.A., JENKINS, D., MAHIDA, Y.R. and HAWKEY, C.J., 2002. Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 8(2), 93-97 BOULTON-JONES, J.R. and HAWKEY, C.J., 2002. Helicobacter pylori and peptic-ulcer disease Lancet. 359(9321), 1943; author reply 1944 HAWKEY, CJ and SKELLY, M.M., 2002. Gastrointestinal safety of selective COX-2 inhibitors Current Pharmaceutical Design. 8(12), 1077-1089 SKELLY, M.M. and HAWKEY, C.J., 2002. Potential alternatives to COX 2 inhibitors BMJ. 324(7349), 1289-1290 HAWKEY, C.J., 2002. NSAID toxicity: where are we and how do we go forward? Journal of Rheumatology. 29(4), 650-652
HAWKEY, C.J., NAESDAL, J., WILSON, I., LÅNGSTRÖM, G., SWANNELL, A.J., PEACOCK, R.A. and YEOMANS, N.D., 2002. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs Gut. 51(3), 336-43 HAWKEY, C.J., 2002. Cyclooxygenase inhibition: between the devil and the deep blue sea Gut. 50(Suppl 3), III25-30
WIGHT, N.J., GOTTESDIENER, K., GARLICK, N.M., ATHERTON, C.T., NOVAK, S., GERTZ, B.J., CALDER, N.A., COTE, J., WONG, P., DALLOB, A. and HAWKEY, C.J., 2001. Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production Gastroenterology. 120(4), 867-873 STACK, W.A., RICHARDSON, P.D., LOGAN, R.P.H., MAHIDA, Y.R. and HAWKEY, C.J., 2001. Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine American Journal of Gastroenterology. 96(7), 2255-2256 HAWKEY, C.J., 2001. NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials? The gastroenterologist's perspective. Clinical and Experimental Rheumatology. 19(6 Suppl 25), S23-30
HAWKEY, C.J., 2001. COX-1 and COX-2 inhibitors Best Practice & Research Clinical Gastroenterology. 15(5), 801-820 SANDBORN, W.J., FEAGAN, B.G., HANAUER, S.B., PRESENT, D.H., SUTBERLAND, L.R., KAMM, M.A., WOLF, D.C., BAKER, J.P., HAWKEY, C. and ARCHAMBAULT, A., 2001. An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial Gastroenterology. 120(6), 1330-1338 HAWKEY, C.J., 2001. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction. American Journal of Medicine. 110(1A), 1S-3S
HAWKEY, C.J., 2001. Journals should see original protocols for clinical trials British Medical Journal. 323(7324), 1309
HAWKEY, C.J. and JONES, J.I., 2001. Gastrointestinal safety of COX-2 specific inhibitors Gastroenterology Clinics of North America. 30(4), 921-36 LONGSTRETH, G.F., HAWKEY, C.J., MAYER, E. A., JONES, R.H., NAESDAL, J., WILSON, I.K., PEACOCK, R.A. and WIKLUND, I.K., 2001. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials Alimentary Pharmacology and Therapeutics. 15(7), 959-964 JONES, J.I. and HAWKEY, C.J., 2001. Physiology and organ-related pathology of the elderly: stomach ulcers Best Practice & Research Clinical Gastroenterology. 15(6), 943-961 HAWKEY, C., 2001. Why doctors should think more carefully before prescribing Hospital Medicine (London). 62(3), 134-135
CHAN, F.K., HAWKEY, C.J. and LANAS, A.I., 2001. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate. American Journal of Medicine. 110(1A), 55S-57S HAWKEY, C.J., LAINE, L., HARPER, S.E., QUAN, H.U., BOLOGNESE, J.A. and MORTENSEN, E., 2001. Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials Alimentary Pharmacology and Therapeutics. 15(10), 1593-601 HAWKEY, C.J., JACKSON, L., HARPER, S.E., SIMON, T.J., MORTENSEN, E. and LINES, C.R., 2001. Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans Alimentary Pharmacology and Therapeutics. 15(1), 1-9 HIRSCHOWITZ, B.I. and HAWKEY, C.J., 2001. Questions regarding future research on aspirin and the gastrointestinal tract American Journal of Medicine. 110(Supp/1A), S74-S78 YEOMANS, N., WILSON, I., LÅNGSTRÖM, G., HAWKEY, C., NAESDAL, J., WALAN, A. and WIKLUND, I., 2001. Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol Scandinavian Journal of Rheumatology. 30(6), 328-334 DUGGAN, A,, BILKU, J., LEDGER, K., SCAFFARDI, R. and HAWKEY, C.J., 2001. Eradicating Helicobacter pylori in patients with a past history of peptic ulcer: is the juice worth the squeeze? Journal of Quality in Clinical Practice. 21(3), 76-79 KUBBA, A.K., SELBY, N.M. and HAWKEY, C.J., 2001. Update in the pharmacological management of peptic ulcer haemorrhage Scandinavian Journal of Gastroenterology. 36(4), 337-342 EMERY, P., HAWKEY, C.J. and MOORE, A., 2001. Prescribing in the UK. Lancet. 357(9258), 809 HAWKEY, G.M., COLE, A.T., MCINTYRE, A.S., LONG, R.G. and HAWKEY, C.J., 2001. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points Gut. 49(3), 372-379 DANESH, J., WHINCUP, P., WALKER, M., LENNON, L., THOMSON, A., APPLEBY, P., HAWKEY, C. and ATHERTON, J.C., 2000. High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population Gut. 47(1), 23-25 DONNELLY, M.T., RICHARDSON, P., HAWKEY, C.J., COURTAULD, E. and STACK, W.A., 2000. Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen Alimentary Pharmacology and Therapeutics. 14(5), 543-9 HAWKEY, C.J., 2000. Nonsteroidal anti-inflammatory drug gastropathy Gastroenterology. 119(2), 521-535 BOMBARDIER, C., LAINE, L., REICIN, A., SHAPIRO, D., BURGOS-VARGAS, R., DAVIS, B., DAY, R., FERRAZ, M.B., HAWKEY, C.J., HOCHBERG, M.C., KVIEN, T.K. and SCHNITZER, T.J., 2000. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group New England Journal of Medicine. 343(21), 1520-8, 2 p following 1528 YEOMANS, N.D., GARAS, G. and HAWKEY, C.J., 2000. The nonsteroidal anti-inflammatory drugs controversy Gastroenterology Clinics of North America. 29(4), 791-806 DONNELLY, M.T., GODDARD, A.F., FILIPOWICZ, B., MORANT, S.V., SHIELD, M.J. and HAWKEY, C.J., 2000. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury Alimentary Pharmacology and Therapeutics. 14(5), 529-534 HAWKEY, C.J., 2000. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers? European Journal of Gastroenterology and Hepatology. 12(1), S17-S20
JACKSON, L.M., WU, K.C., MAHIDA, Y.R., JENKINS, D. and HAWKEY, C.J., 2000. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa Gut. 47(6), 762-770 PATHMAKANTHAN, S. and HAWKEY, C.J., 2000. A lay doctor's guide to the inflammatory process in the gastrointestinal tract Postgraduate Medical Journal. 76(900), 611-617 SELBY, N.M., KUBBA, A.K. and HAWKEY, C.J., 2000. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis' Alimentary Pharmacology and Therapeutics. 14(9), 1119-1126 HAWKEY, C.J., SNOWDEN, J.A., LOBO, A., BEGLINGER, C. and TYNDALL, A., 2000. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues Gut. 46(6), 869-72 JACKSON, L.M. and HAWKEY, C.J., 1999. Gastrointestinal effects of COX-2 inhibitors Expert Opinion on Investigational Drugs. 8(7), 963-971 JACKSON, L.M. and HAWKEY, C.J., 1999. NSAIDs and the GI tract-potential hazards and benefits Apoptosis. 4(5), 397-402